EDSA vs EDIT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EDSA has stronger fundamentals based on our AI analysis.

EDSA
Edesa Biotech, Inc.
SELL
85%
Confidence
VS
EDIT
Editas Medicine, Inc.
STRONG SELL
92%
Confidence

EDSA vs EDIT Fundamental Comparison

Metric EDSA EDIT
Revenue $0.0 $40.5M
Net Income $-2.2M $-160.1M
Net Margin N/A -395.0%
ROE -16.1% -586.6%
ROA -15.3% -85.8%
Current Ratio 16.82x 3.54x
Debt/Equity 0.00x 1.96x
EPS $-0.57 $-1.80

Green = Better metric | Red = Weaker metric

View Full EDSA Analysis →
View Full EDIT Analysis →

You Might Also Compare

EDSA vs AAPL EDIT vs MSFT EDSA vs GOOGL EDIT vs AMZN

EDSA vs EDIT: Frequently Asked Questions

Is EDSA or EDIT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EDSA has stronger fundamentals. EDSA is rated SELL (85% confidence) while EDIT is rated STRONG SELL (92% confidence). This is not investment advice.

How does EDSA compare to EDIT fundamentally?

Edesa Biotech, Inc. has ROE of -16.1% vs Editas Medicine, Inc.'s -586.6%. Net margins are N/A vs -395.0% respectively.

Which stock pays higher dividends, EDSA or EDIT?

EDSA has a dividend yield of N/A or no dividend while EDIT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EDSA or EDIT for long term?

For long-term investing, consider that EDSA has SELL rating with 85% confidence, while EDIT has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EDSA vs EDIT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EDSA vs EDIT, the AI consensus favors EDSA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.